Postprandial PeriodBlood GlucoseGlucoseInsulinHypoglycemic AgentsGlucose Tolerance TestVaccinium vitis-idaeaBreadGlucagon-Like Peptide 1Diabetes Mellitus, Type 2RibesC-PeptideAcarboseMealsGastric EmptyingDietary CarbohydratesImino PyranosesGlucagonGlycemic IndexFastingGlucose IntoleranceHyperglycemiaInsulin Infusion SystemsCross-Over StudiesAsiminaPsylliumHemoglobin A, GlycosylatedGastric Inhibitory PolypeptideBlood Glucose Self-MonitoringArea Under CurveStarchSteviaInsulin, Short-ActingInsulin LisproDietary FiberDiabetic DietHypoglycemiaVaccinium myrtillusDipeptidyl-Peptidase IV InhibitorsEating1-DeoxynojirimycinInsulin AspartSecale cerealeVenomsFatty Acids, NonesterifiedDiabetes Mellitus, Type 1Sodium-Glucose Transporter 2Infusions, SubcutaneousGlycosuriaalpha-GlucosidasesAdamantaneIncretinsSatiety ResponseGlucose OxidaseGlucose Transporter Type 1MetforminMonitoring, AmbulatoryGlucose Transporter Type 4Diabetes MellitusFoodTriglyceridesSulfonylurea CompoundsTime FactorsObesityLipidsDouble-Blind MethodMonosaccharide Transport ProteinsLiverPlacebosGlucose 1-DehydrogenaseDeoxyglucoseGlucose Transporter Type 2Energy IntakeBody WeightReference ValuesInsulin ResistanceGlucose Transporter Type 3Body Mass IndexDietGlycogenGlucose DehydrogenasesGlycolysisGluconeogenesisIslets of LangerhansLactatesDrug Administration ScheduleLactic AcidHexokinaseGlucose-6-PhosphateGlucokinaseFructoseBiological TransportRisk FactorsGlucosephosphatesGlucose Metabolism Disorders3-O-MethylglucoseTreatment OutcomeMethylglucosidesPhlorhizinPeptides